BriaCell Therapeutics shares slipped after the company announced a $15 million equity offering. The stock was recently down 62%, to 78 cents, on the Nasdaq late Tuesday. Shares were between $1.75 and ...

Fewer IPOs and a booming private market mean ordinary investors have less access to fast-growing companies. Here's how that shift affects your portfolio.